Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Pylkäs, Katri ^a   Erkko, Hannele ^a   Nikkilä, Jenni ^a   Sólyom, Szilvia ^a   Winqvist, Robert ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ONCOPROTEIN; PROTEIN PALB2; NUCLEAR PROTEIN; PALB2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; EXON; FAMILY HISTORY; FEMALE; FINLAND; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; GENOME; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; NUCLEOTIDE SEQUENCE; ONSET AGE; OVARY TUMOR; PATHOLOGY; RISK FACTOR;

AGE OF ONSET; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RISK FACTORS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 44949248224     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-146     Document Type: Article

References (27)

1. Vehmanen P Friedman LS Eerola H McClure M Ward B Sarantaus L Kainu T Syrjäkoski K Pyrhönen S Kallioniemi OP Muhonen T Luce M Frank TS Nevanlinna H Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes Hum Mol Genet 1997, 6:2309-2315. 10.1093/hmg/6.13.2309 9361038
2. Huusko P Pääkkönen K Launonen V Pöyhönen M Blanco G Kauppila A Puistola U Kiviniemi H Kujala M Leisti J Winqvist R Evidence of founder mutations in Finnish BRCA1 and BRCA2 families Am J Hum Genet 1998, 62:1544-1548. 1377159 9585608 10.1086/301880
3. Mazoyer S Genomic rearrangements in the BRCA1 and BRCA2 genes Hum Mutat 2005, 25:415-422. 10.1002/humu.20169 15832305
4. Agata S Dalla Palma M Callegaro M Scaini MC Menin C Ghiotto C Nicoletto O Zavagno G Chieco-Bianchi L D'Andrea E Montagna M Large genomic deletions inactivate the BRCA2 gene in breast cancer families J Med Genet 2005, 42:e64. 10.1136/jmg.2005.032789 16199546
5. Woodward AM Davis TA Silva AG Kirk JA Leary JA kConFab Investigators Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families J Med Genet 2005, 42:e31. 1736061 15863663 10.1136/jmg.2004.027961
6. Casilli F Tournier I Sinilnikova OM Coulet F Soubrier F Houdayer C Hardouin A Berthet P Sobol H Bourdon V Muller D Fricker JP Capoulade-Metay C Chompret A Nogues C Mazoyer S Chappuis P Maillet P Philippe C Lortholary A Gesta P Bézieau S Toulas C Gladieff L Maugard CM Provencher DM Dugast C Delvincourt C Nguyen TD Faivre L Bonadona V Frébourg T Lidereau R Stoppa-Lyonnet D Tosi M The contribution of germline rearrangements to the spectrum of BRCA2 mutations J Med Genet 2006, 43:e49. 10.1136/jmg.2005.040212 16950820
7. Lahti-Domenici J Rapakko K Pääkkönen K Allinen M Nevanlinna H Kujala M Huusko P Winqvist R Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families Cancer Genet Cytogenet 2001, 129:120-123. 10.1016/S0165-4608(01)00437-X 11566341
8. Laurila E Syrjäkoski K Holli K Kallioniemi A Karhu R Search for large genomic alterations of the BRCA1 gene in a Finnish population Cancer Genet Cytogenet 2005, 163:57-61. 10.1016/ j.cancergencyto.2005.05.014 16271956
9. Karhu R Laurila E Kallioniemi A Syrjäkoski K Large genomic BRCA2 rearrangements and male breast cancer Cancer Detect Prev 2006, 30:530-534. 10.1016/j.cdp.2006.10.002 17113724
10. Sarantaus L Huusko P Eerola H Launonen V Vehmanen P Rapakko K Gillanders E Syrjäkoski K Kainu T Vahteristo P Krahe R Pääkkönen K Hartikainen J Blomqvist C Löppönen T Holli K Ryynänen M Bützow R Borg Å Wasteson Arver B Holmberg E Mannermaa A Kere J Kallioniemi OP Winqvist R Nevanlinna H Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland Eur J Hum Genet 2000, 8:757-763. 10.1038/ sj.ejhg.5200529 11039575
11. Heikkinen K Rapakko K Karppinen SM Erkko H Knuutila S Lundán T Mannermaa A Børresen-Dale AL Borg Å Barkardottir RB Petrini J Winqvist R RAD50 and NBS1 are Breast Cancer Susceptibility Genes Associated with Genomic Instability Carcinogenesis 2006, 27:1593-1599. 10.1093/carcin/bgi360 16474176
12. Pylkäs K Tommiska J Syrjäkoski K Kere J Gatei M Waddell N Allinen M Karppinen SM Rapakko K Kääriäinen H Aittomäki K Blomqvist C Mustonen A Holli K Khanna KK Kallioniemi OP Nevanlinna H Winqvist R Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer Carcinogenesis 2007, 28:1040-1045. 10.1093/carcin/bgl237 17166884
13. Erkko H Xia B Nikkilä J Schleutker J Syrjäkoski K Mannermaa A Kallioniemi A Pylkäs K Karppinen SM Rapakko K Miron A Sheng Q Li G Mattila H Bell DW Haber DA Grip M Reiman M Jukkola-Vuorinen A Mustonen A Kere J Aaltonen LA Kosma VM Kataja V Soini Y Drapkin RI Livingston DM Winqvist R A recurrent mutation in PALB2 in Finnish cancer families Nature 2007, 446:316-319. 10.1038/nature05609 17287723
14. Rahman N Seal S Thompson D Kelly P Renwick A Elliott A Reid S Spanova K Barfoot R Chagtai T Jayatilake H McGuffog L Hanks S Evans DG Eccles D Breast Cancer Susceptibility Collaboration (UK) Easton DF Stratton MR PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 2007, 39:165-167. 10.1038/ng1959 17200668
15. Tischkowitz M Xia B Sabbaghian N Reis-Filho JS Hamel N Li G van Beers EH Li L Khalil T Quenneville LA Omeroglu A Poll A Lepage P Wong N Nederlof PM Ashworth A Tonin PN Narod SA Livingston DM Foulkes WD Analysis of PALB2/FANCN-associated breast cancer families Proc Natl Acad Sci USA 2007, 104:6788-6793. 1871863 17420451 10.1073/pnas.0701724104
16. Foulkes WD Ghadirian P Akbari MR Hamel N Giroux S Sabbaghian N Darnel A Royer R Poll A Fafard E Robidoux A Martin G Bismar TA Tischkowitz M Rousseau F Narod SA Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women Breast Cancer Res 2007, 9(6):R83. 18053174 2246183 10.1186/bcr1828
17. García MJ Fernández V Osorio A Barroso A Llort G Lázaro C Blanco I Caldés T de la Hoya M Ramón Y Cajal T Alonso C Tejada MI San Román C Robles-Díaz L Urioste M Benítez J Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families Breast Cancer Res Treat 2008 Feb 27
18. Xia B Sheng Q Nakanishi K Ohashi A Wu J Christ N Liu X Jasin M Couch FJ Livingston DM Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 2006, 22:719-729. 10.1016/ j.molcel.2006.05.022 16793542
19. Sellner LN Taylor GR MLPA and MAPH: New techniques for detection of gene deletions Hum Mutat 2004, 23:413-419. 10.1002/humu.20035 15108271
20. Antoniou A Pharoah PD Narod S Risch HA Eyfjörd JE Hopper JL Loman N Olsson H Johannson O Borg Å Pasini B Radice P Manoukian S Eccles DM Tang N Olah E Anton-culver H Warner E Lubinski J Gronwald J Górski B Tulinius H Thorlacius S Eerola H Nevanlinna H Syrjäkoski K Kallioniemi OP Thompson D Evans C Peto J Lalloo F Evans DG Easton DF Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 2003, 72:1117-1130. 1180265 12677558 10.1086/375033
21. Xu CF Chambers JA Solomon E Complex regulation of the BRCA1 gene J Biol Chem, 1997, 272:20994-20997. 10.1074/jbc.272.34.20994 9261099
22. Vahteristo P Eerola H Tamminen A Blomqvist C Nevanlinna H A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Br J Cancer 2001, 84:704-708. 10.1054/ bjoc.2000.1626 11237395
23. Swensen J Hoffman M Skolnick MH Neuhausen SL Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family Hum Mol Genet 1997, 6:1513-1517. 10.1093/hmg/6.9.1513 9285788
24. Puget N Gad S Perrin-Vidoz L Sinilnikova OM Stoppa-Lyonnet D Lenoir GM Mazoyer S Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot Am J Hum Genet 2002, 70:858-865. 379114 11880951 10.1086/339434
25. Gad S Bièche I Barrois M Casilli F Pages-Berhouet S Dehainault C Gauthier-Villars M Bensimon A Aurias A Lidereau R Bressac-de Paillerets B Tosi M Mazoyer S Stoppa-Lyonnet D Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family Hum Mutat 2003, 21:654. 10.1002/humu.9148 14961556
26. Montagna M Dalla Palma M Menin C Agata S De Nicolo A Chieco-Bianchi L D'Andrea E Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families Hum Mol Genet 2003, 12:1055-1061. 10.1093/hmg/ddg120 12700174
27. Hartikainen JM Kataja V Pirskanen M Arffman A Ristonmaa U Vahteristo P Ryynänen M Heinonen S Kosma VM Mannermaa A Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families Clin Genet 2007, 72:311-320. 17850627